Unlocking a new clinical growth channel, built to scale globally

The client is one of the world's most recognized names in weight management, and it was sitting on top of one of the largest underserved audiences in digital health without a product to sell them. Roughly 55% of its members were already in the menopause age range, and 72% of current and lapsed members experiencing symptoms said they wanted a relevant offering. The demand was already inside the member base. The product to meet it did not exist.

Lumenalta®engaged with the US launch date fixed from kickoff and treated as non-negotiable, aligned to a budgeted Q4 paid-media window. International expansion was on the roadmap from the start.

The task was to stand up a complete women's health product line in time for a budgeted paid-media launch, on a six-week runway.

The company had a strategic opening and a hard deadline. Forty-five million American women aged 45 to 60 were experiencing menopause or perimenopause, the brand was not in their consideration set, and paid media dollars were already committed to a Q4 budget spend. Missing the launch date did not mean a late launch. It meant spending against a product that was not there, or holding the spend for a year. Four challenges defined the engagement.

Timeline and scope. The company needed a complete digital experience (microsite, interactive quiz, conversion funnels, MarTech infrastructure, and analytics) live for paid media on a launch date set at kickoff. The week-by-week roadmap was set at kickoff and remained anchored to the original launch date. Days before go-live, the team incorporated critical leadership-driven changes to the quiz flow while keeping delivery on track.

Complex eligibility logic. In the US, the platform had to support two distinct programs, one behavioral and one combining behavioral and clinical services, each with different eligibility paths.

The quiz had to assess menopause stage, symptoms, and clinical fit, then route new members, behavioral members, clinic members, premium members, and returning users into the correct journey. International markets required the Clinic Flow to be hidden entirely. This was the difference between a marketing page and a system that could actually qualify and convert the right people into the right revenue path.

Multi-market launch with regional compliance. Thirteen international markets needed to follow the US quickly, each with localized content, regional compliance requirements, and language-specific quiz flows. The platform handled US clinical data, payment processing, and user consent across nine languages, which is what let the product become a global revenue line rather than a US-only pilot.

Marketing autonomy. On the company's legacy stack, content updates required engineering involvement. For a launch of this scale, with a celebrity campaign, multi-channel paid media, and ongoing A/B testing, the marketing team needed to update pages, swap copy, and run experiments without filing an engineering ticket. Anything less would have capped how fast the funnel could be optimized while paid spend was live. That requirement shaped every architecture decision.

Rather than treat the deadline as a constraint to manage, Lumenalta®built the engagement around the decisions that would let the product launch on time and keep paying off afterward. Five choices, made in the first week, shaped everything that followed.

A six-week plan, locked on day one and held. The week-by-week schedule was published at kickoff and treated as fixed. When leadership called for critical changes to the quiz flow days before launch, the team absorbed them without moving the date. The discipline was commercial, not procedural: the launch was tied to a budgeted paid-media window, and protecting the date protected the spend.

A platform built for marketing autonomy. On the legacy stack, every content change required engineering. Lumenalta®led with a headless CMS (Storyblok) paired with a Next.js and Vercel front end, so marketing could edit pages, swap copy, and run experiments without filing a ticket. That single decision is what made the launch sustainable past the sprint and what let the celebrity campaign run its rapid creative cycles from day one.

An eligibility engine, not a static marketing site. Rather than bolt a quiz onto a brand page, Lumenalta®built an interactive assessment with branching logic at its core. It qualifies users for Clinic or Behavioral, routes them into the right journey, carries over symptom data from prior quizzes, and surfaces education moments that address hesitation about HRT and GLP-1 medications in context. The result is a system that converts the right people into the right revenue path, not a page that collects leads.

Measurement live from the first paid impression. MarTech was not a phase-two item. Event tracking, the CDP, and identity resolution were operational at launch, so the Q4 spend could be measured and optimized from the first impression instead of running blind for weeks.

Built for global scale from the start. The localization framework, market-aware feature flags, and regional compliance handling were in place before international scope began, which turned global expansion into a rollout rather than a rebuild. Automated QA backed the whole effort, with a Playwright suite running in CI on every merge so a revenue-critical funnel stayed safe to change fast.

Lumenalta®built an integrated digital menopause platform that combines content, clinical eligibility, conversion, and analytics in a single architecture, so the product could launch, scale, and be optimized without rework.

Menopause microsite. Brand landing pages and educational content across 14 markets, including US-specific pages covering HRT, the Menopause Relief Kit (Hormone Therapy Kit), program overviews, price comparison, and product detail pages. Built from a reusable component library, so marketing adds new pages and campaigns without engineering involvement.

Interactive eligibility quiz. A personalized menopause assessment with branching logic based on user responses. It determines eligibility for Clinic vs Behavioral and routes users into the appropriate journey (new member, behavioral, clinic, premium, returning, or Registered Dietitian booking), carries over symptom data from prior quizzes so existing members are not asked to repeat themselves, places education moments throughout to handle hesitation about HRT and GLP-1 medications at the point of doubt rather than after it, and offers a "Talk to a Doctor" pathway for users who need clinical guidance before committing.

Conversion and checkout funnels. Optimized signup flows across web and mobile, separate checkout paths for Premium and Clinic, current-member upsell flows, returning-user resume flows, and a Registered Dietitian booking flow (RD1 to RD4). Entry points were integrated into the company's primary website, so the new line pulls from existing traffic alongside paid acquisition.

MarTech infrastructure, live on day one. Google Tag Manager across all touchpoints; multi-platform pixel tracking (Google Ads, Meta, TikTok); Amplitude for behavioral analytics; GA4 for performance metrics; Braze for lifecycle marketing; and a CDP hub-and-spoke model (Hightouch / Segment) unifying customer profiles across sessions and devices, with data flowing into Snowflake for executive reporting. Identity resolution, audience segmentation, and event tracking were operational from the first paid impression, so the Q4 spend could be measured and optimized instead of run blind.

Internationalization framework. Country-specific domains across nine languages, market-aware feature flags (Clinic and HRT content hidden outside the US), and regional compliance embedded in the architecture (HIPAA in the US, GDPR across Europe, CCPA where applicable). A content model built for translation rather than page duplication meant new markets scaled as configuration, not as fresh builds.

Engineering platform. Next.js (App Router) with TypeScript and Tailwind CSS, pnpm for package management, Vercel for hosting, and Fastly for CDN. CircleCI ran CI/CD with Playwright automated testing on every merge, and a blue-green deployment strategy via a stale-prod environment supported zero-downtime domain migration.

The engagement hit every launch date, but the more durable result is what the platform now lets the company do: own a new category, run it without engineering as a bottleneck, and keep expanding it.

Launched on time, end to end

A new market and a new revenue line

Marketing owns the platform

Built to keep moving fast

The company now operates a menopause product line that did not exist months before it launched: live in 14 markets, self-managed by marketing, and built to keep expanding. That platform is the foundation the client is iterating on through the post-launch optimization phase and into the next stage of its product roadmap.